Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients.

• Main Authors: Cynthia Sung (Author), Yuan Wei (Author), Satoru Watanabe (Author), How Sung Lee (Author), Yok Moi Khoo (Author), Lu Fan (Author), Abhay P S Rathore (Author), Kitti Wing-Ki Chan (Author), Milly M Choy (Author), Uma S Kamaraj (Author), October M Sessions (Author), Pauline Aw (Author), Paola F de Sessions (Author), Bernett Lee (Author), John E Connolly (Author), Martin L Hibberd (Author), Dhanasekaran Vijaykrishna (Author), Limin Wijaya (Author), Eng Eong Ooi (Author), Jenny Guek-Hong Low (Author), Subhash G Vasudevan (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2016-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

UNLABELLED:CELADEN was a randomized placebo-controlled trial of 50 patients with confirmed dengue fever to evaluate the efficacy and safety of celgosivir (A study registered at ClinicalTrials.gov, number NCT01619969). Celgosivir was given as a 400 mg loading dose and 200 mg bid (twice a day) over 5...